These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 17215848

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
    Andrés A, Morales E, Morales JM, Bosch I, Campo C, Ruilope LM, Valsartan in Renal Transplantation Group.
    Transplant Proc; 2006 Oct; 38(8):2419-23. PubMed ID: 17097955
    [Abstract] [Full Text] [Related]

  • 23. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC, Ayala DE, Khder Y, Calvo C.
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [Abstract] [Full Text] [Related]

  • 24. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 25. Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study.
    Fogari R, Malamani G, Zoppi A, Mugellini A, Rinaldi A, Fogari E, Perrone T.
    Clin Ther; 2007 Mar; 29(3):413-8. PubMed ID: 17577462
    [Abstract] [Full Text] [Related]

  • 26. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination.
    Kostis JB.
    Am J Ther; 2010 Mar; 17(2):188-96. PubMed ID: 19433970
    [Abstract] [Full Text] [Related]

  • 27. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS, Rector TS, Kuskowski M, Thomas S, Holwerda NJ, Cohn JN.
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness and safety of high-dose valsartan monotherapy in hypertension treatment: the ValTop study.
    Parati G, Asmar R, Bilo G, Kandra A, Di Giovanni R, Mengden T.
    Hypertens Res; 2010 Oct; 33(10):986-94. PubMed ID: 20686486
    [Abstract] [Full Text] [Related]

  • 29. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients.
    Nakamura T, Fujii S, Hoshino J, Saito Y, Mizuno H, Saito Y, Kurabayashi M.
    Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331
    [Abstract] [Full Text] [Related]

  • 30. Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy.
    Cai J, Huang Z, Yang G, Cheng K, Ye Q, Ming Y, Zuo X, Zhou P, Yuan H.
    Am J Cardiovasc Drugs; 2011 Dec 01; 11(6):401-9. PubMed ID: 22149319
    [Abstract] [Full Text] [Related]

  • 31. Haemodynamic effects of AT1 inhibition and Ca2+-channel blockade in hypertensive patients during isometric stress.
    Arosio E, De Marchi S, Prior M, Rigoni A, Lechi A.
    J Hum Hypertens; 2006 Mar 01; 20(3):201-5. PubMed ID: 16319906
    [Abstract] [Full Text] [Related]

  • 32. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr 01; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 33. Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients.
    Fogari R, Zoppi A, Maffioli P, Lazzari P, Mugellini A, Derosa G.
    Expert Opin Pharmacother; 2011 Nov 01; 12(16):2441-8. PubMed ID: 21958068
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.
    Schunkert H, Glazer RD, Wernsing M, Yen J, Macarie CE, Vintila MM, Romanova J.
    Curr Med Res Opin; 2009 Nov 01; 25(11):2655-62. PubMed ID: 19751115
    [Abstract] [Full Text] [Related]

  • 35. Time to achieve blood pressure goal with a combination versus a conventional monotherapy approach in hypertensive patients with metabolic syndrome.
    Fogari R, Zoppi A, Ferrari I, Mugellini A, Preti P, Derosa G.
    Clin Exp Hypertens; 2010 Nov 01; 32(5):245-50. PubMed ID: 20662723
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug 01; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 37. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I, Saruta T, ADVANCE-Combi Study Group.
    Hypertens Res; 2006 Oct 01; 29(10):789-96. PubMed ID: 17283866
    [Abstract] [Full Text] [Related]

  • 38. Cost-effectiveness analysis: controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) study.
    Saito I, Fujikawa K, Saruta T, ADVANCE-Combi Study Group.
    Hypertens Res; 2008 Jul 01; 31(7):1399-405. PubMed ID: 18957811
    [Abstract] [Full Text] [Related]

  • 39. Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study.
    Yarows SA, Oparil S, Patel S, Fang H, Zhang J.
    Adv Ther; 2008 Dec 01; 25(12):1288-302. PubMed ID: 19066757
    [Abstract] [Full Text] [Related]

  • 40. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep 01; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.